TRNS · Transcat Inc · Documents

Aug 7

Quarterly report 10-Q FY2025 Q1, ended Jun 29

Quarterly report for FY2025 Q1

Revenue $66.71M ▲ 10.1% Net income $4.41M ▲ 49.5% Diluted EPS $0.48 ▲ 26.3%

Jul 30

Earnings call

Q1 2025 earnings call

Jul 30

Current report 8-K

Financial results

Jul 23

Proxy statement DEF 14A Meeting Sep 11, 2024

Proxy statement

Jul 23

Annual report to holders ARS

Annual report to holders

Jul 23

Proxy statement DEFA14A

Proxy statement

Jul 12

Proxy statement PRE 14A Meeting Sep 11, 2024

Proxy statement

May 30

Registration statement S-3ASR

Registration statement

May 28

Annual report 10-K FY2024, ended Mar 30

Annual report for FY2024

Revenue $259.48M ▲ 12.5% Net income $13.65M ▲ 27.7% Diluted EPS $1.63 ▲ 16.4%

May 22

Current report 8-K/A Events of May 16

Director or officer change, or executive pay

May 21

Earnings call

Q4 2024 earnings call

May 21

Current report 8-K

Financial results

May 20

Current report 8-K Events of May 16

Director or officer change, or executive pay

May 20

Current report 8-K

Entered into a material agreement

Apr 15

Current report 8-K

Entered into a material agreement, Completed an acquisition or sale of assets, Unregistered sale of equity, Regulation FD disclosure

Apr 10

Current report 8-K/A Events of Apr 8

Current report

Apr 9

Current report 8-K Events of Apr 8

Director or officer change, or executive pay, Regulation FD disclosure

Jan 31

Quarterly report 10-Q FY2024 Q3, ended Dec 23

Quarterly report for FY2024 Q3

Revenue $65.17M ▲ 13.5% Net income $3.35M ▲ 109.1% Diluted EPS $0.38 ▲ 81.0%

Jan 30

Earnings call

Q3 2024 earnings call

Jan 30

Current report 8-K

Financial results

Jan 30

Current report 8-K Events of Jan 24

Director or officer change, or executive pay

Nov 15

Current report 8-K

Regulation FD disclosure

Nov 1

Quarterly report 10-Q FY2024 Q2, ended Sep 23

Quarterly report for FY2024 Q2

Revenue $62.8M ▲ 11.3% Net income $460K ▼ 80.5% Diluted EPS $0.06 ▼ 80.6%

Oct 31

Earnings call

Q2 2024 earnings call

Oct 31

Current report 8-K Events of Oct 30

Financial results

Oct 30

Current report 8-K Events of Oct 26

Director or officer change, or executive pay

Sep 28

Current report 8-K Events of Sep 27

Other events

Sep 21

Current report 8-K Events of Sep 20

Entered into a material agreement, Other events

Sep 12

Current report 8-K Events of Sep 11

Entered into a material agreement

Sep 7

Current report 8-K Events of Sep 6

Shareholder vote results

Aug 17

Registration statement S-3

Registration statement

Aug 10

Registration statement S-3/A

Registration statement

Aug 8

Current report 8-K

Entered into a material agreement, Completed an acquisition or sale of assets, Unregistered sale of equity, Regulation FD disclosure

Aug 2

Quarterly report 10-Q FY2024 Q1, ended Jun 24

Quarterly report for FY2024 Q1

Revenue $60.6M ▲ 10.9% Net income $2.95M ▼ 4.0% Diluted EPS $0.38 ▼ 5.0%

Aug 2

Registration statement S-3

Registration statement

Aug 1

Earnings call

Q1 2024 earnings call

Aug 1

Current report 8-K Events of Jul 31

Financial results

Jul 20

Proxy statement DEF 14A Meeting Sep 6, 2023

Proxy statement

Jul 20

Registration statement S-3/A

Registration statement

Jul 20

Annual report to holders ARS

Annual report to holders

Jul 20

Proxy statement DEFA14A

Proxy statement

Jul 12

Current report 8-K

Other events

Jun 6

Annual report 10-K FY2023, ended Mar 25

Annual report for FY2023

Revenue $230.57M ▲ 12.5% Net income $10.69M ▼ 6.1% Diluted EPS $1.40 ▼ 6.7%

May 30

Registration statement S-3/A

Registration statement

May 22

Earnings call

Q4 2023 earnings call

May 22

Current report 8-K

Financial results

May 22

Current report 8-K Events of May 16

Director or officer change, or executive pay

May 19

Registration statement S-3

Registration statement

Mar 28

Current report 8-K Events of Mar 27

Unregistered sale of equity, Regulation FD disclosure

Feb 1

Quarterly report 10-Q FY2023 Q3, ended Dec 24

Quarterly report for FY2023 Q3

Revenue $57.4M ▲ 12.8% Net income $1.6M ▼ 1.7% Diluted EPS $0.21 ▲ unchanged